Relmada names Jørn Skibsted Jakobsen chief development officer for urology
AI Summary- Relmada appointed Jørn Skibsted Jakobsen Chief Development Officer, Urology & Uro-Oncology.
- Jakobsen will lead the planned Phase 3 SPECTRUM program for NDV-01.
- He previously led Ferring’s pivotal ADSTILADRIN development program.